Skip to main content
. 2009 Jun;156(3):552–561. doi: 10.1111/j.1365-2249.2009.03925.x

Fig. 2.

Fig. 2

Kaplan–Meier analysis of development of pneumococcal pneumonia in ovalbumin (OVA)-treated versus non-treated control mice challenged with pneumococci (P = 0·022). The OVA-treated and control mice were challenged intranasally with pneumococci and followed for the development of pneumococcal infection for 7 days.